Arcutis Biotherapeutics (ARQT) Capital Expenditures (2019 - 2026)
Arcutis Biotherapeutics (ARQT) reported Capital Expenditures of $158,000 for Q2 2026, up 102.6% from $78,000 a year earlier.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Capital Expenditures (2019 - 2026) Analysis & Trends
For FY2025, Arcutis Biotherapeutics posted Capital Expenditures of $686,000, up 379.7% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 16.4% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $143,000 in FY2024 (-66.6%), $428,000 in FY2023 (+28.5%), $333,000 in FY2022 (-66.5%) and $995,000 in FY2021 (+210.0%).
- The Q2 2026 figure ranks as the highest quarterly Capital Expenditures since Q1 2025.
- The high point for year-over-year Capital Expenditures in five years was Q3 2023 (growth of 966.7%); the low point was Q3 2022 (a decline of 95.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Arcutis Biotherapeutics | 3.36 Bn | 2.64 Bn | 118.92 Mn | 158,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 158,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 608,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 64,000.00 |
| Jun 30, 2023 | 276,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 80,000.00 |
| Mar 31, 2022 | 124,000.00 |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | 137,000.00 |
| Jun 30, 2021 | 43,000.00 |
| Mar 31, 2021 | 554,000.00 |
| Dec 31, 2020 | 153,000.00 |
| Sep 30, 2020 | 110,000.00 |
| Jun 30, 2020 | 17,000.00 |
| Mar 31, 2020 | 41,000.00 |
API Access
Arcutis Biotherapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();